BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33549322)

  • 1. Utilising mass cytometry with CD45 barcoding and standardised leucocyte phenotyping for immune trajectory assessment in critically ill patients.
    Fish M; Ellis R; Bishop C; Todd K; Petrov N; Singer M; Swanson CM; Shankar-Hari M
    Br J Anaesth; 2021 Apr; 126(4):e149-e152. PubMed ID: 33549322
    [No Abstract]   [Full Text] [Related]  

  • 2. Ratiometric Barcoding for Mass Cytometry.
    Wu X; DeGottardi Q; Wu IC; Wu L; Yu J; Kwok WW; Chiu DT
    Anal Chem; 2018 Sep; 90(18):10688-10694. PubMed ID: 30139253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD45-based barcoding approach to multiplex mass-cytometry (CyTOF).
    Lai L; Ong R; Li J; Albani S
    Cytometry A; 2015 Apr; 87(4):369-74. PubMed ID: 25645694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mass-Ratiometry-Based CD45 Barcoding Method for Mass Cytometry Detection.
    Meng H; Warden A; Zhang L; Zhang T; Li Y; Tan Z; Wang B; Li H; Jiang H; Shen G; Hong Y; Ding X
    SLAS Technol; 2019 Aug; 24(4):408-419. PubMed ID: 30856358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucocyte identification and analysis in human semen.
    Maietta G; Fiore JR; Pellegrino V; Milillo G; Tagliaferro L; Corbelli M; Pastore G
    Arch Androl; 1997; 38(2):99-105. PubMed ID: 9049030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry.
    Schulz AR; Mei HE
    Methods Mol Biol; 2019; 1989():93-108. PubMed ID: 31077101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmonized analysis of PBMC by mass cytometry.
    Schulz AR; Rademacher J; Bockhorn V; Mei HE
    Methods Cell Biol; 2024; 186():107-130. PubMed ID: 38705596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and immunophenotyping of mononuclear cells from human lung tissue.
    Shimizu T; Fujimori F; Shimaoka Y; Narita J; Takada T; Tajima S; Moriyama H; Terada M; Suzuki E; Gejyo F
    Intern Med; 2007; 46(4):163-9. PubMed ID: 17301510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry.
    Leipold MD; Newell EW; Maecker HT
    Methods Mol Biol; 2015; 1343():81-95. PubMed ID: 26420710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive immune dysregulation in critically ill ICU patients.
    Duggal NA; Snelson C; Shaheen U; Pearce V; Lord JM
    Sci Rep; 2018 Jul; 8(1):10186. PubMed ID: 29976949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver nanoparticles for the detection of cell surface antigens in mass cytometry.
    Schulz AR; Stanislawiak S; Baumgart S; Grützkau A; Mei HE
    Cytometry A; 2017 Jan; 91(1):25-33. PubMed ID: 27351740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.
    Tchilian EZ; Wallace DL; Imami N; Liao HX; Burton C; Gotch F; Martinson J; Haynes BF; Beverley PC
    J Immunol; 2001 May; 166(10):6144-8. PubMed ID: 11342634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing Mass Cytometry at the Bedside to Study the Immunological Basis of Human Diseases: Distinctive Immune Features in Patients with a History of Term or Preterm Birth.
    Gaudillière B; Ganio EA; Tingle M; Lancero HL; Fragiadakis GK; Baca QJ; Aghaeepour N; Wong RJ; Quaintance C; El-Sayed YY; Shaw GM; Lewis DB; Stevenson DK; Nolan GP; Angst MS
    Cytometry A; 2015 Sep; 87(9):817-29. PubMed ID: 26190063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection.
    Tchilian EZ; Wallace DL; Dawes R; Imami N; Burton C; Gotch F; Beverley PC
    AIDS; 2001 Sep; 15(14):1892-4. PubMed ID: 11579257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sample fixation and the use of LDS-751 or anti-CD45 for leukocyte identification in mouse whole blood for flow cytometry.
    Maes ML; Davidson LB; McDonagh PF; Ritter LS
    J Immunol Methods; 2007 Jan; 319(1-2):79-86. PubMed ID: 17187818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilizing Antibody Cocktails for Mass Cytometry.
    Schulz AR; Baumgart S; Schulze J; Urbicht M; Grützkau A; Mei HE
    Cytometry A; 2019 Aug; 95(8):910-916. PubMed ID: 31058420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of leukocyte populations in Canadian Holsteins classified as high or low immune responders for antibody- or cell-mediated immune response.
    Hine BC; Cartwright SL; Mallard BA
    Can J Vet Res; 2012 Apr; 76(2):149-56. PubMed ID: 23024458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Cell Barcoding for Efficient Analysis of Small Samples by Mass Cytometry.
    Wagar LE
    Methods Mol Biol; 2019; 1989():125-135. PubMed ID: 31077103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy.
    Garg SK; Ott MJ; Mostofa AGM; Chen Z; Chen YA; Kroeger J; Cao B; Mailloux AW; Agrawal A; Schaible BJ; Sarnaik A; Weber JS; Berglund AE; Mulé JJ; Markowitz J
    Front Immunol; 2020; 11():164. PubMed ID: 32161584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice.
    Wang J; Liu X; Lu H; Jiang C; Cui X; Yu L; Fu X; Li Q; Wang J
    Brain Behav Immun; 2015 Mar; 45():98-108. PubMed ID: 25526817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.